Balduyck M, Mizon C, Loutfi H, Richet C, Roussel P, Mizon J
Eur J Biochem. 1986 Jul 15;158(2):417-22. doi: 10.1111/j.1432-1033.1986.tb09769.x.
The major urinary trypsin inhibitor (Mr 44 000), isolated from human urine, contains 35% carbohydrate. In addition to N-acetylglucosamine and neutral sugars (primarily mannose and galactose), the carbohydrate moiety contains hexuronic acid and N-acetylgalactosamine and corresponds to a glycosaminoglycan. This carbohydrate chain is an integral component of the inhibitor: it does not dissociate from the inhibitor when using dissociative conditions such as sodium dodecyl sulfate, guanidinium chloride, or by increasing ionic strength or mixing with cetylpyridinium chloride. This glycosaminoglycan chain is sensitive to chondroitinase ABC or testicular hyaluronidase digestion and corresponds to slightly sulfated chondroitin 4-sulfate or 6-sulfate. After treatment by these enzymes, the urinary inhibitor has a lower molecular mass (Mr 26 000) but still inhibits trypsin.
从人尿中分离出的主要尿胰蛋白酶抑制剂(分子量44000)含有35%的碳水化合物。除了N-乙酰葡糖胺和中性糖(主要是甘露糖和半乳糖)外,碳水化合物部分还含有己糖醛酸和N-乙酰半乳糖胺,相当于一种糖胺聚糖。这条碳水化合物链是抑制剂的一个组成部分:在使用十二烷基硫酸钠、氯化胍等解离条件时,或者通过增加离子强度或与十六烷基氯化吡啶混合,它都不会与抑制剂解离。这条糖胺聚糖链对软骨素酶ABC或睾丸透明质酸酶消化敏感,相当于轻度硫酸化的硫酸软骨素4-硫酸盐或6-硫酸盐。经这些酶处理后,尿抑制剂的分子量较低(分子量26000),但仍能抑制胰蛋白酶。